ARC Desk

Insulin Delivery Devices Market Size Poised to Touch US$22.5 Bn up to 2026

Lehdistötiedote   •   Tammi 03, 2020 14:18 EET

The global ​insulin delivery devices market size is set to reach over US$ 22.5 billion by 2026 and will grow at CAGR 7.2% during the forecast period 2019-2026. Acumen Research and Consulting, Latest Research Report on titled “insulin delivery devices market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”.

In the coming years, the global insulin delivery devices market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2026. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global insulin delivery devices market , the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1636

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry. The market share of the global insulin delivery devices market is dominated by companies like Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Insulet, Ypsomed, Becton Dickinson, and others. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global insulin delivery devices market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the insulin delivery devices market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the insulin delivery devices market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the insulin delivery devices market in terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Diabetes Clinics & Centers

Market By End Use

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Homecare

Market By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global insulin delivery devices market ?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Insulin Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Insulin Delivery Devices Market By Type
1.2.2.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Insulin Delivery Devices Market Revenue Share By Type in 2018
1.2.2.3. Insulin Syringe
1.2.2.4. Insulin Pens
1.2.2.5. Insulin Jet Injectors
1.2.2.6. Insulin Pumps
1.2.2.7. Insulin Needles
1.2.2.8. Insulin Inhalers
1.2.3. Insulin Delivery Devices Market By Distribution Channel
1.2.3.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.1.1. Hospital Pharmacies
1.2.3.1.2. Retail Pharmacies
1.2.3.1.3. Online Sales
1.2.3.1.4. Diabetes Clinics & Centers
1.2.4. Insulin Delivery Devices Market By End Use
1.2.4.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Ambulatory Care Centers
1.2.4.5. Homecare
1.2.5. Insulin Delivery Devices Market By Geography
1.2.5.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Insulin Delivery Devices Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Insulin Delivery Devices Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Insulin Delivery Devices Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Insulin Delivery Devices Major Manufacturers in 2018

CHAPTER 4. INSULIN DELIVERY DEVICES MARKET BY TYPE
4.1. Global Insulin Delivery Devices Revenue By Type
4.2. Insulin Syringe
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Insulin Pens
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Insulin Jet Injectors
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Insulin Pumps
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Insulin Needles
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Insulin Needles
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Insulin Inhalers
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. INSULIN DELIVERY DEVICES MARKET BY DISTRIBUTION CHANNEL
5.1. Global Insulin Delivery Devices Revenue By Distribution Channel
5.2. Hospital Pharmacies
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Retail Pharmacies
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Online Sales
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Diabetes Clinics & Centers
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. INSULIN DELIVERY DEVICES MARKET BY END USE
6.1. Global Insulin Delivery Devices Revenue By End Use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Ambulatory Care Centers
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Homecare
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
7.1. North America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Insulin Delivery Devices Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE INSULIN DELIVERY DEVICES MARKET BY COUNTRY
8.1. Europe Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
10.1. Latin America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
11.1. Middle East & AFRICA Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & AFRICA Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Novo Nordisk
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Sanofi
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Eli Lilly
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medtronic
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Insulet
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Ypsomed
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Becton Dickinson
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Others
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1636

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.